Skip to main content

AstraZeneca coronavirus vaccine found to be 79% effective in U.S. trial

The coronavirus vaccine developed by AstraZeneca and the University of Oxford has been found to be 79% effective in a large U.S. trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.